BioWorld Science

Nov. 20, 2020

View Archived Issues

Nanoparticle fights pancreatic cancer's chemo resistance

Read More

FLUVID influenza-COVID-19 therapeutic cocktail demonstrates effective antiviral activity

Read More

Lumasiran approved in the E.U. for the treatment of PH1

Read More

First patient dosed in phase I study of SEFA-1024

Read More

Black Swan Pharmaceuticals patents antisense oligonucleotides targeting SOD1

Read More

New CD73 inhibitors discovered at Abbisko Therapeutics

Read More

Sotatercept for RV-PA coupling and RV function improvement in PAH

Read More

Sichuan Kelun-Biotech Biopharmaceutical identifies new STING agonists

Read More

New HBsAg and HBeAg secretion inhibitors discovered at Nanjing Hepo Pharmaceuticals

Read More

Jiangsu Carefree Pharmaceutical synthesizes new tyrosine kinase receptors inhibitors

Read More

Promore reports phase IIb data on ropocamptide for venous leg ulcers

Read More

Promising preclinical data for AK-119 as potential immunotherapy for COVID-19

Read More

Investigators plant better AID for protein degradation

Read More

Nourin-dependent miR-137 as early diagnostic biomarker for unstable angina

Read More

Phase III RATIONALE 303 trial of tislelizumab in NSCLC meets primary endpoint at interim analysis

Read More

IL-2-antibody fusion shows promising effects in metastatic melanoma and breast cancer murine models

Read More

FDA issues EUA for baricitinib with remdesivir for hospitalized COVID-19 patients

Read More

AVO-101: promising results for weight loss and NASH reduction

Read More

New trial evaluates F4 Pharma's FX-06 in patients with severe COVID-19

Read More

Novel mouse model allows efficacy evaluation of checkpoint inhibitors targeting CD28

Read More

Enrollment begins in registrational trial of Nyxol to reverse pharmacologically induced mydriasis

Read More